Peptic ulcer disease

Current Problems in Surgery

Volumn 42, Issue 6, 2005, Pages 346-454

  Harbison, Sean P ^a   Dempsey, Daniel T ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; ANTIBIOTIC AGENT; ANTIULCER AGENT; BISMUTH SALICYLATE; CELECOXIB; CIMETIDINE; CLARITHROMYCIN; COCAINE; HISTAMINE H2 RECEPTOR ANTAGONIST; IBUPROFEN; LANSOPRAZOLE; METRONIDAZOLE; MISOPROSTOL; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RANITIDINE BISMUTH CITRATE; ROFECOXIB; STOMACH SECRETION INHIBITOR; TETRACYCLINE; UREA; UREASE;

ALCOHOL CONSUMPTION; ANGIOGRAPHY; BACTERIUM CULTURE; CIGARETTE SMOKING; CLINICAL TRIAL; DISEASE PREDISPOSITION; DRUG UTILIZATION; ELECTIVE SURGERY; ENDOSCOPIC THERAPY; ERADICATION THERAPY; EVIDENCE BASED MEDICINE; FIBERSCOPE ENDOSCOPY; GASTRECTOMY; GASTRECTOMY BILLROTH II; GASTROINTESTINAL SURGERY; GASTROJEJUNOSTOMY; HELICOBACTER PYLORI; HEMOSTASIS; HIGHLY SELECTIVE VAGOTOMY; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MEDICAL DECISION MAKING; MENTAL STRESS; META ANALYSIS; MINIMALLY INVASIVE SURGERY; MORTALITY; PATHOPHYSIOLOGY; PEPTIC ULCER; PEPTIC ULCER BLEEDING; PHYSICIAN ATTITUDE; PREVALENCE; PYLOROPLASTY; RECURRENT PEPTIC ULCER; REOPERATION; REVIEW; SELECTIVE VAGOTOMY; SEROLOGY; STOMACH ACID SECRETION; STOMACH ANTRUM RESECTION; STOMACH OBSTRUCTION; SWEDEN; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ULCER PERFORATION; UREA BREATH TEST; VAGOTOMY;

EID: 21044433445     PISSN: 00113840     EISSN: None     Source Type: Journal    
DOI: 10.1067/j.cpsurg.2005.02.005     Document Type: Note

References (301)

1. J. Friedenwald A clinical study of a thousand cases of ulcer of the stomach and duodenum Am J Med Sci 144 1912 157-170
2. A. Mendeloff What has been happening to duodenal ulcer? Gastroenterology 67 1974 1020-1022
3. A.C. Ivy The problem of peptic ulcer JAMA 132 1946 1053-1059
4. J.N. Morris R.M. Titmuss Epidemiology of peptic ulcer: Vital statistics Lancet 2 1944 841-845
5. R.A.L. Sturdevant Epidemiology of peptic ulcer Am J Epidemiol 104 1976 9-14
6. T.M. Vogt R.E. Johnson Recent changes in the incidence of duodenal and gastric ulcer Am J Epidemiol 111 1980 713-720
7. C.M. Wylie The complex wane of peptic ulcer: Trends in duodenal ulcer admission to 790 hospitals, 1974-1979 J Clin Gastroenterol 3 1981 333-339
8. B.E. Stabile E. Passaro Jr Duodenal ulcer, a disease in evolution Curr Prob Surg 21 1984 1-79
9. A.J. McKay C.S. McArdle Cimetidine and perforated peptic ulcer Br J. Surg 69 1982 319-320
10. D.B. McConnell G.C. Baba C.W. Deveney Changes in surgical treatment of peptic ulcer disease within a Veterans Hospital in the 1970s and the 1980s Arch Surg 124 1989 1164-1167
11. P. Primatesta M.J. Goldacre V. Seagroatt Changing patterns in the epidemiology and hospital care of peptic ulcer Int J Epidemiol 23 1994 1206-1217
12. J.I. Isenberg The impact of H2 receptor antagonists on the complications, morbidity, and mortality of peptic ulcer disease Aliment Pharmacol Ther 1 suppl 1 1987 447S-454S
13. P.E. Donahue Ulcer surgery and highly selective vagotomy - Y2K Arch Surg 134 1999 1373-1377
14. J.S. Spechler Peptic ulcer disease and its complications In: M. Feldman editor. Sleisenger and Fordtran's Gastrointestinal and Liver Disease 7th ed. 2002 Elsevier Philadelphia, PA 747-781
15. J.Q. Huang S. Sridhar R.H. Hunt Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: A meta-analysis Lancet 359 2002 14-22
16. J.H. Kurata A.N. Nogawa Meta-analysis of risk factors for peptic ulcer: nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking J Clin Gastroenterol 24 1997 2-17
17. C. Svanes J.A. Soreide A. Skarstein et al. Smoking and ulcer perforation Gut 41 1997 177-180
18. H.R. Mertz J.H. Walsh Peptic ulcer pathophysiology Med Clin North Am 75 1991 799-814
19. B.J. Marshall J.R. Warren Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration Lancet 1 1984 1311-1315
20. H. Cohen Peptic ulcer and Helicobacter pylori Gastroenterol Clin North Am 29 2000 775-789
21. A. Nomura G.N. Stemmermann P.H. Chyou et al. Helicobacter pylori infection and the risk for duodenal and gastric ulceration Ann Intern Med 120 1994 977-981
22. D.Y. Graham G.M. Lew P.D. Klein et al. Effect of treatment of H pylori infection on the long-term recurrence of gastric or duodenal ulcer: A randomized, controlled study Ann Intern Med 116 1992 705-708
23. E. Hentschel G. Brandstatter B. Dragosics et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer N Engl J Med 328 1993 308-312
24. R.J. Hopkins L.S. Girardi E.A. Turney Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: A review Gastroenterology 110 1996 1244-1252
25. R.W.M. Van der Hulst E.A.J. Rauws B. Koycu et al. Prevention of ulcer recurrence after eradication of Helicobacter pylori: A prospective long-term follow-up study Gastroenterology 113 1997 1082-1086
26. A. Leodolter M. Kulig H. Brasch W. Meyer-Sabellek S.N. Willich P. Malfertheiner A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcer Alimentary Pharmacol Ther 15 2001 1949-1958
27. L. Laine R.J. Hopkins L.S. Girardi Has the impact of H. pylori therapy on ulcer recurrence in the United States been overstated: A meta-analysis of rigorously designed trials Am J Gastroenterol 93 1998 1409-1415
28. M.J. Blaser Not all Helicobacter pylori strains are created equal should all be eliminated? Lancet 349 1997 1020-1022
29. R.M. Peek Jr M.J. Blaser Pathophysiology of Helicobacter pylori-induced gastritis and peptic ulcer disease Am J Med 102 1997 200-207
30. L. Laine Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient Gastroenterology 120 2001 594-606
31. W.L. Peterson D.Y. Graham Helicobacter pylori In: M. Feldman editor. Sleisenger and Fordtran's Gastrointestinal and Liver Disease 7th ed. 2002 Elsevier Philadelphia, PA 732-746
32. M.B. Fennerty Helicobacter pylori Arch Int Med 154 1994 721-727
33. R.M. Gerata D.Y. Graham Images in clinical medicine N Engl J Med 335 1996 250 (comment)
34. G.L. Kauffman Duodenal ulcer disease: Treatment by surgery, antibiotics, or both? Adv Surg 34 2000 121-135
35. A.W. Harris P.A. Gummett J.J. Misiewicz J.H. Baron Eradication of Helicobacter pylori in patients with duodenal ulcer lowers basal and peak acid outputs to gastrin releasing peptide and pentagastrin Gut 38 1996 663-667
36. M.J. Blaser D.E. Berg Helicobacter pylori genetic diversity and risk of human disease J Clin Invest 107 2001 767-773
37. D.Y. Graham R.E. Rakel A.M. Fendrick et al. Recognizing peptic ulcer disease - keys to clinical and laboratory diagnosis Postgrad Med 105 1999 113-133
38. J.H. Walsh W.L. Peterson The treatment of Helicobacter pylori infection in the management of peptic ulcer disease N Engl J Med 333 1995 984-991
39. G. Manes A. Balzano G. Iaquinto et al. Accuracy of the stool antigen test in the diagnosis of Helicobacter pylori infection before treatment and in patients on omeprazole therapy Aliment Pharmacol Ther 15 2001 73-79
40. W.J. Lee M.S. Wu C.N. Chen R.H. Yuan J.T. Lin K.J. Chang Seroprevalence of Helicobacter pylori in patients with surgical peptic ulcer Arch Surg 132 1997 430-434
41. D. Vaira M. Menegatti M. Miglioli What is the role of Helicobacter pylori in complicated peptic ulcer disease Gastroenterology 113 1997 S78-S84
42. A.J. Blair M. Feldman C. Barnett et al. Detailed comparison of basal and food-stimulated gastric acid secretion rates and serum gastrin concentrations in duodenal ulcer patients and normal subjects J Clin Invest 79 1987 582-587
43. M. Feldman C.T. Richardson Total 24-hour gastric acid secretion in patients with duodenal ulcer: Comparison with normal subjects and effects of cimetidine and parietal cell vagotomy Gastroenterology 90 1986 540-544
44. A.M. Cox Stomach size and its relation to chronic peptic ulcer Arch Pathol 54 1952 407-422
45. E. Amdrup M. Brandsborg O. Brandsborg N.A. Lovgreen Interrelationship between serum gastrin concentration, gastric acid secretion, and gastric emptying rate in recurrent peptic ulcer World J Surg 3 1979 235-240
46. J.I. Isenberg J.A. Selling D.L. Hogan M.A. Koss Impaired proximal duodenal mucosal bicarbonate secretion in patients with duodenal ulcer N Engl J Med 316 1987 374-379
47. M.I. Grossman J.B. Kirsner I.E. Gillespie Basal and histalog-stimulated gastric secretion in control subjects and in patients with peptic ulcer or gastric cancer Gastroenterology 45 1963 14
48. R.S. Fisher S. Cohen Pyloric-sphincter dysfunction in patients with gastric ulcer N Engl J Med 288 1973 273-276
49. W.P. Ritchie Jr Acute gastric mucosal damage induced by bile salts, acid, and ischemia Gastroenterology 68 1975 699-707
50. M.M. Wolfe D.R. Lichtenstein G. Singh Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs N Engl J Med 340 1999 1888-1899
51. F.L. Lanza and the Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology Practice parameters of the American College of Gastroenterology: A guideline for the treatment and prevention of NSAID induced ulcers Am J Gastroenterol 93 1998 2037-2046
52. W.H. Aldoori E.L. Giovannucci M.J. Stampfer et al. A prospective study of alcohol, smoking, caffeine, and the risk of duodenal ulcer in men Epidemiology 8 1997 420-424
53. B. Cryer E. Lee M. Feldman Factors influencing gastroduodenal mucosal prostaglandin concentrations: Roles of smoking and aging Ann Intern Med 116 1992 636-640
54. M.A. Ainsworth D.L. Hogan M.A. Koss J.I. Isenberg Cigarette smoking inhibits acid-stimulated duodenal mucosal bicarbonate secretion Ann Intern Med 119 1993 882-886
55. D.V. Feliciano J.C. Ojukwu G.S. Rozycki et al. The epidemic of cocaine-related juxtapyloric perforations: With a comment on the importance of testing for Helicobacter pylori Ann Surg 229 1999 801-804
56. S. Levenstein S. Ackerman J.K. Kiecolt-Glaser A. Dubois Stress and peptic ulcer disease JAMA 281 1999 10-11
57. S. Gustavsson O. Nyren Time trends in peptic ulcer surgery, 1956 to 1986: A nation-wide survey in Sweden Ann Surg 210 1989 704-709
58. S. Gustavsson K.A. Kelly L.J. Melton 3rd A.R. Zinsmeister Trends in peptic ulcer surgery: A population-based study in Rochester, Minnesota, 1956-1985 Gastroenterology 94 1988 688-694
59. A. Christensen R. Bousfield J. Christiansen Incidence of perforated and bleeding peptic ulcers before and after the introduction of H2-receptor antagonists Ann Surg 207 1988 4-6
60. C.E. Welch G.V. Rodkey P. von Ryll Gryska A thousand operations for ulcer disease Ann Surg 204 1986 454-467
61. M. Susser Z. Stein Civilization and peptic ulcer Lancet 1 1962 115-119
62. A. Sonnenberg Temporal trends and geographical variations of peptic ulcer disease Aliment Pharmacol Ther 9 suppl 2 1995 3-12
63. H.B. El-Serag A. Sonnenberg Opposing time trends of peptic ulcer and reflux disease Gut 43 1998 327-333
64. D.Y. Graham H.M. Malaty D.G. Evans et al. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States Gastroenterology 100 1991 1495-1501
65. B. Cryer M. Feldman Peptic ulcer disease in the elderly Semin Gastrointest Dis 5 1994 166-178
66. S. Hernandez-Diaz L.A. Rodriguez Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/ perforation: An overview of epidemiologic studies published in the 1990s Arch Intern Med 160 2000 2093-2099
67. M.M. Wolfe G. Sachs Acid suppression: Optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress related erosive syndrome Gastroenterology 118 2000 S9-S31
68. A. Walan J.P. Bader M. Classen C.B. Lamers D.W. Piper K. Rutgersson et al. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer N Engl J Med 320 1989 69-75
69. N. Gitlin A.J. McCullough J.L. Smith et al. A multicenter, double-blind, randomized, placebo-controlled comparison of nocturnal and twice-a-day famotidine in the treatment of active duodenal ulcer disease Gastroenterology 92 1987 48-53
70. C.P.M. Dekkers J.A. Beker B. Thjodleifsson et al. Comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of active duodenal ulcer: A European multicentre study Aliment Pharmacol Ther 13 1999 179-186
71. T. Poynard M. Lemaire H. Agostini Meta-analysis of randomized clinical trials comparing lansoprazole with rantidine or famotidine in the treatment of acute duodenal ulcers Eur J Gastroenterol Hepatol 7 1995 661-665
72. N.D. Yeomans Z. Tulassay L. Juhasz et al. ASTRONAUT study group A comparison of omeprazole with rantidine for ulcers associated with nonsteroidal anti-inflammatory drugs N Engl J Med 338 1998 719-726
73. K.E. McArthur Therapy of the uncomplicated ulcer Semin Gastrointest Dis 4 1993 27-38
74. S.R. Tunis I.A. Sheinhait C.H. Schmid D.J. Bishop S.D. Ross Lansoprazole compared with histamine2-receptor antagonists in healing gastric ulcers: a meta-analysis Clin Ther 19 1997 743-757
75. S. Holt C.W. Howden Omeprazole: Overview and opinion Dig Dis Sci 36 1991 385-393
76. D.W. Burget S.G. Chiverton R.H. Hunt Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression Gastroenterology 99 1990 345-351
77. M. Feldman Gastric secretion In: M. Feldman editor. Sleisenger and Fordtran's Gastrointestinal and Liver Disease 7th ed. 2002 Elsevier Philadelphia, PA 715-731
78. N. Zeng C. Athmann T. Kang et al. PACAP type I receptor activation regulates ECL cells and gastric acid secretion J Clin Invest 104 1999 1383-1391
79. 2 Am J Physiol Gastrointest Liver Physiol 278 2000 G121-G127
80. X. Calvet N. Garcia T. Lopez et al. A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin, and either metronidazole or amoxycillin for treating Helicobacter pylori infection Aliment Pharmacol Ther 14 2000 603-609
81. J.S. Hoffman D.R. Cave Treatment of Helicobacter pylori Curr Opin Gastroenterol 17 2001 30-34
82. M.P. Dore G. Leandro G. Realdi et al. Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy Dig Dis Sci 45 2000 68-76
83. D.Y. Graham M.S. Osato J. Hoffman et al. Furazolidone combination therapies for Helicobacter pylori infection in the United States Aliment Pharmacol Ther 14 2000 211-215
84. K. Trebesius K. Panthel S. Strobel et al. Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridization Gut 46 2000 608-614
85. J. Ikewaki A. Nishizono T. Goto et al. Therapeutic oral vaccination induces mucosal immune response sufficient to eliminate long-term Helicobacter pylori infection Microbiol Immunol 44 2000 29-39
86. J. Danesh P. Appleby R. Peto How often does surgery for peptic ulceration eradicate Helicobacter pylori? Systematic review of 36 studies BMJ 316 1998 746-747
87. A. Lanas C. Sekar B.I. Hirschowitz Objective evidence of aspirin use in both ulcer and non-ulcer and lower gastrointestinal bleeding Gastroenterology 103 1992 862-869
88. A. Lanas P. Serrano E. Bajador et al. Evidence of aspirin use in both upper and lower gastrointestinal perforation Gastroenterology 112 1997 683-689
89. M.C. Allison A.G. Howatson C.J. Torrance F.D. Lee R.I. Russell Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs N Engl J Med 327 1992 749-754
90. S.E. Gabriel L. Jaakkimainen C. Bombardier Risks for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: A meta-analysis Ann Intern Med 115 1991 787-796
91. H.B. El-Serag D.Y. Graham P. Richardson J.M. Inadomi Prevention of complicated ulcer disease among chronic users of non-steroidal anti-inflammatory drugs: The use of a nomagram and cost effectiveness analysis Arch Intern Med 162 2002 2105-2110
92. F. Silverstein G. Faich J.L. Goldstein et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The CLASS study: A randomized controlled trial JAMA 284 2000 1247-1255
93. C. Bombardier L. Laine A. Reicin et al. Comparison of upper intestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis N Engl J Med 343 2000 1520-1528
94. L. Laine The GI effects of nonselective NSAIDs & COX2 selective inhibitors Semin Arthritis Rheum 32 2002 25-32
95. C.J. Hawkey J.A. Karrasch L. Szczepanski et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal anti-inflammatory drugs: The OMNIUM study N Engl J Med 338 1998 727-734
96. B. Cryer M. Feldman Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans Gastroenterology 117 1999 17-25
97. G. Treiber J.R. Lambert The impact of Helicobacter pylori eradication on peptic ulcer healing Am J Gastroenterol 93 1998 1080-1084
98. C.J. Hawkey Omeprazole NSAID Steering Committee Progress in prophylaxis against nonsteroidal anti-inflammatory drug-associated ulcers and erosions Am J Med 104 3A 1998 67S-74S
99. The SALT Collaborative Group Swedish aspirin low-dose trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events Lancet 338 1991 1345-1349
100. J. Butler R. Ness T. Speroff Improving care for elderly patients with peptic ulcer disease: Should the focus be on drugs or bugs? JAMA 286 2001 2023-2024
101. L.A. Garcia Rodriguez Nonsteroidal antiinflammatory drugs, ulcers and risk: A collaborative meta-analysis Semin Arthritis Rheum 26 6 suppl 1 1997 16-20
102. A. Rostom G. Wells P. Tugwell V. Welch C. Dube J. McGowan The prevention of chronic NSAID induced upper gastrointestinal toxicity: A Cochrane collaboration metaanalysis of randomized controlled trials J Rheumatol 27 2000 2203-2214
103. A. Rostom C. Dube G. Wells P. Tugwell V. Welch E. Jolicoeur et al. NSAID induced gastroduodenal ulcers: Cochrane Database of Systematic Reviews 4 2002 CD002296
104. F.K.L. Chau J.Y.L. Ching L.C.T. Hung et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding N Engl J Med 352 2005 238-244
105. M.J. Langman D.M. Jensen D.J. Watson S.E. Harper P.L. Zhao H. Quan et al. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs JAMA 282 1999 1929-1933
106. J.L. Wallace Distribution and expression of cyclooxygenase (COX) isoenzymes, their physiological roles, and the categorization of nonsteroidal anti-inflammatory drugs (NSAIDs) Am J Med 107 6A 1999 11S-17S
107. S. Fiorucci L. Santucci J.L. Wallace M. Sardina M. Romano P. del Soldato et al. Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa Proc Natl Acad Sci USA 100 2003 10937-10941
108. E.J. Topol Arthritis, medicines and cardiovascular events - "house of coxibs." JAMA 293 2005 366-368
109. S. Gottlieb Warnings issued over COX2 inhibitors in US and UK BMJ 330 2005 9
110. F.E. Silverstein D.Y. Graham J.R. Senior et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs: A randomized double blind placebo controlled trial Ann Intern Med 123 1995 241-249
111. M. Koch A. Dezi F. Ferrario I. Capurso Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury: A meta-analysis of randomized controlled clinical trials Arch Intern Med 156 1996 2321-2332
112. M. Koch L. Capurso A. Dezi F. Ferrario C. Scarpignato Prevention of NSAID-induced gastroduodenal mucosal injury: Meta-analysis of clinical trials with misoprostol and H2-receptor antagonists Dig Dis 13 suppl 1995 62-74
113. D.M. McCarthy Sucralfate N Engl J Med 325 1991 1017-1025
114. J. Brock A. Sauaia D. Ahnen et al. Process of care and outcomes for elderly patients hospitalized with peptic ulcer disease: Results from a quality improvement project JAMA 286 2001 1985-1993
115. H.M. Hood C. Wark P.A. Burgess D. Nicewander M.W. Scott Screening for Helicobacter pylori and nonsteroidal anti-inflammatory drug use in medicare patients hospitalized with peptic ulcer disease Arch Intern Med 159 1999 149-154
116. A.D. Gilliam W.J. Speake D.N. Lobo I.J. Beckingham Current practice of emergency vagotomy and Helicobacter pylori eradication for complicated peptic ulcer in the United Kingdom Br J Surg 90 2003 88-90
117. L.H. Lickstein J.B. Matthews Elective surgical management of peptic ulcer disease Prob Gen Surg 14 1997 37-53
118. R.C. Moesinger C.J. Yeo In: G.D. Zuidema C.J. Yeo editors. Shackelford's Surgery of the Alimentary Tract 5th ed. 2002 Saunders Philadelphia, PA 57-73
119. D.M. Jensen S. Uyou E. Pelayo M.E. Jensen et al. The Prevalence of Helicobacter pylori and NSAID use in patients with severe UGI hemorrhage and their potential role in recurrence of ulcer bleeding Gastroenterology 102 1992 A90
120. M. Sebastian V.P. Chandran Y.I. Elashaal A.J. Sim Helicobacter pylori infection in perforated peptic ulcer disease Br J Surg 82 1995 360-362
121. D.H. Reinbach G. Cruickshank K.E. McColl Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection Gut 34 1993 1344-1347
122. D. Vaira M. Menegatti M. Miglioli What is the role of Helicobacter pylori in complicated ulcer disease? Gastroenterology 113 suppl 1997 S78-S84
123. Y.T. Lee J.J.Y. Sung C.L. Choi et al. Ulcer recurrence after gastric surgery: Is helicobacter pylori the culprit? Am J Gastroenterol 93 1998 928-931
124. S.M. Buring L.H. Winner R.C. Hatton P.L. Doering Discontinuation rates of Helicobacter pylori treatment regimens: A meta-analysis Pharmacotherapy 19 1999 324-332
125. J.M. Seager C.J. Hawkey ABC of the upper gastrointestinal tract: indigestion and non-steroidal anti-inflammatory drugs BMJ 323 2001 1236-1239
126. J. Perrault C.R. Fleming R.R. Dozois Surreptitious use of salicylates: A cause of chronic recurrent gastroduodenal ulcers Mayo Clin Proc 63 1988 337-342
127. B.G.A. Moynihan Duodenal Ulcer 1910 WB Saunders Philadelphia
128. J.M.T. Finney E.M. Hanrahan The surgical treatment of duodenal ulcer: end results over a 25 year period Ann Surg 90 1929 904-917
129. O.H. Wangensteen A critique of operations for peptic ulcer Postgrad Med 23 1958 466-483
130. W.F. Ballinger 2nd T.F. Solanke Serosal patch pyloroplasty Surg Gynecol Obstet 122 1966 1283-1288
131. J.A. Weinberg S.J. Stempien H.J. Movius A.E. Dagradi Vagotomy and pyloroplasty in the treatment of duodenal ulcer Am J Surg 92 1956 202-207
132. E.R. Woodward M.M. Eisenberg L.R. Dragstedt Recurrence of gastric ulcer after pyloroplasty: A note of warning Am J Surg 113 1967 5-12
133. A. Codivilla Considerations on 40 cases of gastric surgery Bull Med Sci 9 1898 651-717
134. W.J. Mayo Ulcers of the duodenum from a surgical standpoint BMJ 2 1906 1299-1302
135. G.J. Heuer C. Holman W.A. Cooper Treatment of Peptic Ulcer 1944 Lippincott Philadelphia
136. H.N. Harkins The surgical treatment of duodenal ulcer 1884 to 1965 J Natl Med Assoc 57 1965 365-373
137. H. Finsterer F. Cunha The surgical treatment of duodenal ulcer Surg Gynecol Obstet 52 1931 1099-1114
138. R.R. Graham Technical surgical procedures for gastric and duodenal ulcer Surg Gynecol Obstet 66 1938 269-287
139. S.E. Newton 3rd E.S. Judd Long term follow-up proves Billroth I gastric resection inadequate for permanent control of duodenal ulcer Surg Gynecol Obstet 116 1963 170-174
140. W.G. Rhea Jr D.A. Killen H.W. Scott Jr Long term results of partial gastric resection without vagotomy in duodenal ulcer disease Surg Gynecol Obstet 120 1965 970-974
141. L.F. Dragstedt P.V. Harper F.R. Tovee E.R. Woodward Section of the vagus nerves to the stomach in the treatment of peptic ulcer Ann Surg 126 1947 687-692
142. C.A. Griffith H.N. Harkins Selective gastric vagotomy: Physiologic basis and technique Surg Clin North Am 42 1962 1431-1441
143. H.N. Harkins L.S. Stavney C.A. Griffith L.E. Savage L.M. Nyhus Selective gastric vagotomy Postgrad Med 35 1964 289-298
144. D. Andersen H. Hostrup E. Amdrup The Aarhus county vagotomy trial. II. An interim report on reduction in acid secretion and ulcer recurrence rate following parietal cell vagotomy and selective gastric vagotomy World J Surg 2 1978 91-100
145. T. Kennedy G.W. Johnston K.D. Macrae A.F. Spencer Proximal gastric vagotomy: Interim results of a randomized controlled trial BMJ 2 1975 301-303
146. P.H. Jordan Jr J. Thornby Twenty years after parietal cell vagotomy or selective vagotomy antrectomy for treatment of duodenal ulcer: Final report Ann Surg 220 1994 283-296
147. J.L. Herrington Jr Gastroduodenal ulcer: Overview of 150 papers presented before the Southern Surgical Association 1888-1986 Ann Surg 207 1988 754-769
148. M. Feldman R.M. Dickerman R.N. McClelland K.A. Cooper J.H. Walsh C.T. Richardson Effect of selective proximal vagotomy on food-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer Gastroenterology 76 5 pt 1 1979 926-931
149. J. Christiansen H.E. Jensen P. Ejby-Poulsen L. Bardram F.W. Henriksen Prospective controlled vagotomy trial for duodenal ulcer: Primary results, sequelae, acid secretion, and recurrence rates two to five years after operation Ann Surg 193 1981 49-55
150. M.W. Gear Proximal gastric vagotomy versus long-term maintenance treatment with cimetidine for chronic duodenal ulcer: A prospective randomised trial Br Med J Clin Res Ed 286 1983 98-99
151. H. Harling I. Balslev E. Bentzen Parietal cell vagotomy or cimetidine maintenance therapy for duodenal ulcer? A prospective controlled trial Scand J Gastroenterol 20 1985 747-750
152. M. Strom G. Bodemar J. Lindhagen R. Sjodahl A. Walan Cimetidine or parietal-cell vagotomy in patients with juxtapyloric ulcers Lancet 2 1984 894-897
153. W. Mistiaen R. Van Hee P. Blockx A. Hubens Gastric emptying for solids in patients with duodenal ulcer before and after highly selective vagotomy Dig Dis Sci 35 1990 310-316
154. P.E. Donahue C. Griffith H.M. Richter A 50-year perspective upon selective gastric vagotomy Am J Surg 172 1996 9-12
155. P.H. Jordan Jr J. Thornby Should it be parietal cell vagotomy or selective vagotomy-antrectomy for treatment of duodenal ulcer? A progress report Ann Surg 205 1987 572-590
156. N.J. Soper K.A. Kelly J.A. van Heerden D.M. Ilstrup Long term clinical results after proximal gastric vagotomy Surg Gynecol Obstet 169 1989 488-494
157. G.W. Johnston E.F.A. Spencer A.J. Wilkinson T.L. Kennedy Proximal gastric vagotomy: Follow-up at 10-20 years Br J Surg 78 1991 20-23
158. F. Cohen P. Valleur J. Serra D. Brisset L. Chiche P. Hautefeuille Relationship between gastric acid secretion and the rate of recurrent ulcer after parietal cell vagotomy Ann Surg 217 1993 253-259
159. R. Brancatisano G.L. Falk J.W. Hollinshead D.J. Gillet Bleeding duodenal ulceration: The results of emergency treatment with highly selective vagotomy Aust N Z J Surg 62 1992 725-728
160. K. Dittrich W. Blauensteiner C. Schrutka-Kolbl F. Hoffer C. Armbruster J. Vavrik Highly selective vagotomy plus Jaboulay: A possible alternative in patients with benign stenosis secondary to duodenal ulceration J Am Coll Surg 180 1995 654-658
161. T.F. Gorey F. Lennon S.J. Heffernan Highly selective vagotomy in duodenal ulceration and its complications: A 12-year review Ann Surg 200 1984 181-184
162. A.G. Johnson Proximal gastric vagotomy: Does it have a place in the future management of peptic ulcer? World J Surg 24 2000 259-263
163. P.H. Jordan Jr Technique of parietal cell vagotomy Surgical Rounds 1990 17-28 September
164. P.E. Donahue H.M. Richter K.J. Liu K. Anan L.M. Nyhus Experimental basis and clinical application of extended highly selective vagotomy for duodenal ulcer Surg Gynecol Obstet 176 1993 39-48
165. T.V. Taylor J.P. Lythgoe J.B. McFarland et al. Anterior lesser curve seromyotomy and posterior truncal vagotomy versus truncal vagotomy and pyloroplasty in the treatment of chronic duodenal ulcer Br J Surg 77 1990 1007-1009
166. A. Cuschieri Laparoscopic vagotomy - gimmick or reality? Surg Clin North Am 72 1992 357-367
167. J. Mouiel N. Katkhouda Laparoscopic vagotomy for chronic duodenal ulcer disease World J Surg 17 1993 34-39
168. P.H. Jordan Jr Indications for parietal cell vagotomy without drainage in gastrointestinal surgery Ann Surg 210 1989 29-41
169. P.E. Donahue Parietal cell vagotomy versus vagotomy-antrectomy: Ulcer surgery in the modern era World J Surg 24 2000 264-269
170. K. Tominaga Distribution of parietal cells in the antral mucosa of human stomachs Gastroenterology 69 1975 1201-1207
171. H.T. Debas Proximal gastric vagotomy interferes with a fundic inhibitory mechanism: A hypothesis for the high recurrence rate of peptic ulceration Am J Surg 146 1983 51-56
172. M.E. Skellenger P.H. Jordan Jr Complications of vagotomy and pyloroplasty Surg Clin North Am 63 1983 1167-1180
173. G.G. Jamieson Current status of indications for surgery in peptic ulcer disease World J Surg 24 2000 256-258
174. T. Kennedy G.W. Johnston A.H. Love A.M. Connell E.F. Spencer Pyloroplasty versus gastrojejunostomy: Results of a double-blind, randomized, controlled trial Br J Surg 60 1973 949-953
175. L.J. Skandalakis P.E. Donahue J.E. Skandalakis The vagus nerve and its vagaries Surg Clin North Am 73 1993 769-784
176. J.L. Herrington Jr J.L. Sawyers Results of elective duodenal ulcer surgery in women: Comparison of truncal vagotomy and antrectomy, gastric selective vagotomy and pyloroplasty, proximal gastric vagotomy Ann Surg 187 1978 576-582
177. H.T. Debas Surgical management of peptic ulcer disease J Assoc Acad Minor Phys 3 1992 137-141
178. J.L. Herrington J.L. Sawyers Gastric ulcer Curr Probl Surg 24 1987 759-865
179. P.H. Jordan Jr Type I gastric ulcer treated by parietal cell vagotomy and mucosal ulcerectomy J Am Coll Surg 182 1996 388-393
180. P.E. Donahue L.M. Nyhus Surgical excision of gastric ulcers near the gastroesophageal junction Surg Gynecol Obstet 155 1982 85-88
181. A. Csendes I. Braghetto F. Calvo R. De la Cuadra N. Velasco H. Schutte et al. Surgical treatment of high gastric ulcer Am J Surg 149 1985 765-770
182. J.L. Herrington Historical aspects of gastric surgery In: H.W. Scott J.L. Sawyers editors. Surgery of the Stomach, Duodenum, and Small Intestine 2nd ed. 1992 Blackwell Scientific Publications Oxford, England 1-28
183. F. Dubois New surgical strategy for gastroduodenal ulcer: Laparoscopic approach World J Surg 24 2000 270-276
184. H.L. Laws M.J. Naughton J.B. McKernan Thoracoscopic vagectomy for recurrent peptic ulcer disease Surg Laparosc Endosc 2 1992 24-28
185. R.C. Thirlby M. Feldman Transthoracic vagotomy for postoperative peptic ulcer: Effects on basal, sham feeding- and pentagastrin-stimulated acid secretion and on clinical outcome Ann Surg 201 1985 648-655
186. M. Anvari A. Park Laparoscopic assisted vagotomy and distal gastrectomy Surg Endosc 8 1994 1312-1315
187. P. Goh Y. Tekant J. Isaac et al. The technique of laparoscopic Billroth II gastrectomy Surg Laparosc Endosc 2 1992 258-260
188. J.C. Goligher C.N. Pulvertaft G. Watkinson Controlled trial of vagotomy and gastroenterostomy, vagotomy and antrectomy, and subtotal gastrectomy in elective treatment of duodenal ulcer: Interim report BMJ 5381 1964 455-460
189. J.C. Goligher C.N. Pulvertaft T.T. Irvin et al. Five to eight year results of truncal vagotomy and pyloroplasty for duodenal ulcer BMJ 1 1972 7-13
190. P.H. Jordan R.E. Condon A prospective evaluation of vagotomy-pyloroplasty and vagotomy-antrectomy for treatment of duodenal ulcer Ann Surg 172 1970 547-563
191. O. Kronborg P. Madsen A controlled randomized trial of highly selective vagotomy versus selective vagotomy and pyloroplasty in the treatment of duodenal ulcer Gut 16 1975 268-271
192. T. Kennedy G.W. Hohnston K.D. Macrae et al. Proximal gastric vagotomy: interim results of a randomized controlled trial BMJ 2 1975 301-303
193. C.J. Stoddard J.S. Vassilakis H.L. Duthie Highly selective vagotomy or truncal vagotomy and pyloroplasty for chronic duodenal ulceration: A randomized, prospective clinical study Br J Surg 65 1978 793-796
194. P. Aeberhard M. Walther Results of a controlled randomized trial of proximal gastric vagotomy with and without pyloroplasty Br J Surg 65 1978 634-636
195. N.J. Dorricott A.R. Mcneish J. Alexander-Williams C.M. Royston W.M. Cooke C.J. Spencer et al. Prospective randomized multicentre trial of proximal gastric vagotomy or truncal vagotomy and antrectomy for chronic duodenal ulcer: Interim results Br J Surg 65 1978 152-154
196. A. Faxen Parietal cell vagotomy and selective vagotomy with pyloroplasty: A prospective randomized study Scand J Gastroenterol Suppl 51 1978 1-32
197. C.G. Koffman J.B. Elder I.E. Gillespie et al. A prospective randomized trial of vagotomy in chronic duodenal ulceration Br J Surg 66 1979 145-148
198. D.C. Dunn W.E. Thomas J.O. Hunter An evaluation of highly selective vagotomy in the treatment of chronic duodenal ulcer Surg Gynecol Obstet 150 1980 845-849
199. J.B. Elder P.C. Ganguli C.C. Koffman et al. Randomized trial of elective highly selective or truncal vagotomy in chronic duodenal ulceration Can J Surg 26 1983 119-122
200. J. Koo S.K. Lam P. Chan N.W. Lee P. Lam J. Wong et al. Proximal gastric vagotomy, truncal vagotomy with drainage, and truncal vagotomy with antrectomy for chronic duodenal ulcer: A prospective, randomized controlled trial Ann Surg 197 1983 265-271
201. A.G. Fraser P.W. Brunt N.A. Matheson A comparison of highly selective vagotomy with truncal vagotomy and pyloroplasty-one surgeon's results after 5 years Br J Surg 70 1983 485-488
202. J.J. Gleysteen R.E. Condon E.J. Tapper Prospective trial of proximal gastric vagotomy Surgery 94 1983 15-20
203. P.E. Donahue C.T. Bombeck R.E. Condon L.M. Nyhus Proximal gastric vagotomy: Versus selective vagotomy with antrectomy results of a prospective, randomized clinical trial after four to twelve years Surgery 96 1984 585-591
204. M. Strom G. Bodemar J. Lindhagen R. Sjodahl A. Walan Cimetidine or parietal-cell vagotomy in patients with juxtapyloric ulcers Lancet 2 1984 894-897
205. C.J. Stoddard A.G. Johnson H.L. Duthie The four to eight year results of the Sheffield trial of elective duodenal ulcer surgery - highly selective or truncal vagotomy Br J Surg 71 1984 779-782
206. H. Harling I. Balslev E. Bentzen Parietal cell vagotomy or cimetidine maintenance therapy for duodenal ulcer? A prospective controlled trial Scand J Gastroenterol 20 1985 747-750
207. H.J. Oostvogel T.J. van Vroonhoven Anterior lesser curve seromyotomy with posterior truncal vagotomy versus proximal gastric vagotomy Br J Surg 75 1988 121-124
208. B.A. Elfberg F. Nilsson O. Selking Parietal cell vagotomy and truncal vagotomy in elective duodenal ulcer surgery - results after six to twelve years Ups J Med Sci 94 1989 129-136
209. J. Hoffmann H.E. Jensen J. Christiansen A. Olesen F.B. Loud O. Hauch Prospective controlled vagotomy trial for duodenal ulcer: Results after 11-15 years Ann Surg 209 1989 40-45
210. N.M. Koruth K.S. Dua P.W. Brunt N.A. Matheson Comparison of highly selective vagotomy with truncal vagotomy and pyloroplasty: Results at 8-15 years Br J Surg 77 1990 70-72
211. S. Emas B. Eriksson Twelve-year follow-up of a prospective, randomized trial of selective vagotomy with pyloroplasty and selective proximal vagotomy with and without pyloroplasty for the treatment of duodenal, pyloric, and prepyloric ulcers Am J Surg 164 1992 4-12
212. S. Emas G. Grupcev B. Eriksson Six-year results of a prospective, randomized trial of selective proximal vagotomy with and without pyloroplasty in the treatment of duodenal, pyloric, and prepyloric ulcers Ann Surg 217 1993 6-14
213. H.S. Walia H.A. Abd el-Karim Anterior lesser curve seromyotomy with posterior truncal vagotomy versus proximal gastric vagotomy: Results of a prospective randomized trial 3-8 years after surgery World J Surg 18 1994 758-763
214. V.M. Chan R.K. Reznick K. O'Rourke J.M. Kitchens A.G. Lossing A.S. Detsky Meta-analysis of highly selective vagotomy versus truncal vagotomy and pyloroplasty in the surgical treatment of uncomplicated duodenal ulcer Can J Surg 37 1994 457-464
215. A. Csendes F. Maluenda I. Braghetto H. Schutte P. Burdiles J.C. Diaz Prospective randomized study comparing three surgical techniques for the treatment of gastric outlet obstruction secondary to duodenal ulcer Am J Surg 166 1993 45-49
216. D.A. Reid H.L. Duthie C.J. Bransom A.G. Johnson Late follow-up of highly selective vagotomy with excision of the ulcer compared with Billroth I gastrectomy for treatment of benign gastric ulcer Br J Surg 69 1982 605-607
217. S. Emas G. Grupcev B. Eriksson Ten-year follow-up of a prospective, randomized trial of selective proximal vagotomy with ulcer excision and partial gastrectomy with gastroduodenostomy for treating corporeal gastric ulcer Am J Surg 167 1994 596-600
218. D.L. Morris P.C. Hawker S. Brearley M. Simms P.W. Dykes M.R. Keighley Optimal timing of operation for bleeding peptic ulcer: Prospective randomised trial Br Med J Clin Res Ed 288 1984 1277-1280
219. E. Saperas J.M. Pique R. Perez Ayuso J.M. Bordas J. Teres C. Pera Conservative management of bleeding duodenal ulcer without a visible vessel: Prospective randomized trial Br J Surg 74 1987 784-786
220. B. Millat J.M. Hay P. Valleur A. Fingerhut P.L. Fagniez Emergency surgical treatment for bleeding duodenal ulcer: Oversewing plus vagotomy versus gastric resection, a controlled randomized trial French Associations for Surgical Research World J Surg 17 1993 568-574
221. V.A. Poxon M.R.B. Keighley P.W. Dykes et al. Comparison of minimal and conventional surgery in patients with bleeding peptic ulcer: A multicenter trial Br J Surg 78 1991 1344-1345
222. C. Ohmann M. Imhof R. Hans-Dietrich Trends in peptic ulcer bleeding and surgical treatment World J Surg 24 2000 284-293
223. J. Boey N.W. Lee J. Koo P.H. Lam J. Wong G.B. Ong Immediate definitive surgery for perforated duodenal ulcers: A prospective controlled trial Ann Surg 196 1982 338-344
224. J. Boey F.J. Branicki T.T. Alagaratnam P.J. Fok S. Choi A. Poon et al. Proximal gastric vagotomy: The preferred operation for perforations in acute duodenal ulcer Ann Surg 208 1988 169-174
225. C. Gutierrez de la Pena R. Marquez F. Fakih E. Dominguez-Adame J. Medina Simple closure or vagotomy and pyloroplasty for the treatment of a perforated duodenal ulcer: Comparison of results Dig Surg 17 2000 225-228
226. K. Singh R.S. Chhina A. Ghosh R. Kaura Impact of ranitidine on prognosis after simple closure of perforated duodenal ulcer Trop Gastroenterol 20 1999 90-92
227. E.K. Ng Y.H. Lam J.J. Sung M.Y. Yung K.F. To A.C. Chan et al. Eradication of Helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation: Randomized controlled trial Ann Surg 231 2000 153-158
228. V. Kate N. Ananthakrishnan S. Badrinath Effect of Helicobacter pylori eradication on the ulcer recurrence rate after simple closure of perforated duodenal ulcer: Retrospective and prospective randomized controlled studies Br J Surg 88 2001 1054-1058
229. H.H. McGuire Jr J.S. Horsley 3rd. Emergency operations for gastric and duodenal ulcers in high risk patients Ann Surg 203 1986 551-557
230. Anonymous Therapeutic endoscopy and bleeding ulcers. National Institutes of Health Consensus Development Conference Consensus Statement JAMA 262 1989 1369-1372
231. T.A. Rockall R.F. Logan H.B. Devlin T.C. Northfield Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage BMJ 311 1995 222-226
232. T.A. Rockall Management and outcome of patients undergoing surgery after acute upper gastrointestinal haemorrhage: Steering Group for the National Audit of Acute Upper Gastrointestinal Haemorrhage J R Soc Med 91 1998 518-523
233. F.E. Silverstein D.A. Gilbert F.J. Tedesco N.K. Buenger J. Persing The National ASGE Survey on Upper GI Bleeding II Clinical Prognostic Factors Gastrointest Endosc 27 1981 80-93
234. D.A. Gilbert Epidemiology of upper gastrointestinal bleeding Gastrointest Endosc 36 1990 S8-S13
235. S. Lee M. Iida T. Yao S. Shindo M. Fujishima H. Okabe Long-term follow-up of 2529 patients with gastric and duodenal ulcer: Survival rate and causes of death Gastroenterology 94 1988 381-386
236. D.A. Corley A.M. Stefan M. Wolf E.F. Cook T.H. Lee Early indicators of prognosis in upper gastrointestinal hemorrhage Am J Gastroenterol 93 1998 336-340
237. D. Vaira M. Menegatti M. Miglioli What is the role of Helicobacter pylori in complicated peptic ulcer disease Gastroenterology 113 1997 S78-S84
238. Consensus Conference Therapeutic endoscopy and bleeding ulcers JAMA 262 1989 1369-1372
239. E.K. Ng S.C. Chung J.T. Lau J.J. Sung J.W. Leung S.A. Raimes et al. Risk of further ulcer complications after an episode of peptic ulcer bleeding Br J Surg 83 1996 840-844
240. J.Y. Lau J.J. Sung A.C. Chan G.W. Lai J.T. Lau E.K. Ng Stigmata of hemorrhage in bleeding peptic ulcers: An interobserver agreement study among international experts Gastrointest Endosc 46 1997 33-36
241. R.A. Cowles M.W. Mulholland Surgical management of peptic ulcer disease in the helicobacter era - management of bleeding peptic ulcer Surg Laparosc Endosc Percutan Tech 11 2001 1-8
242. J.E. Levine G.I. Leontiadis V.K. Sharma C.W. Howden Meta-analysis: The efficacy of intravenous H2-receptor antagonists in bleeding peptic ulcer Aliment Pharmacol Ther 16 2002 1137-1142
243. J.P. Gisbert L. Gonzalez X. Calvet M. Roque R. Gabriel J.M. Pajares Proton pump inhibitors versus H2-antagonists: A meta-analysis of their efficacy in treating bleeding peptic ulcer Aliment Pharmacol Ther 15 2001 917-926
244. M. Bustamante N. Stollman The efficacy of proton pump inhibitors in acute ulcer bleeding - a qualitative review J Clin Gastroenterol 30 2000 7-13
245. J.Y. Lau J.J. Sung K.K. Lee M.Y. Yung S.K. Wong J.C. Wu et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers N Engl J Med 343 2000 310-316
246. D.M. Jensen S. Cheng T.O. Kovacs G. Randall M.E. Jensen T. Reedy et al. A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer N Engl J Med 330 1994 382-386
247. C.W. Howden How many patients must we treat for Helicobacter pylori infection to prevent a recurrent duodenal ulcer hemorrhage? Gastrointest Endosc 43 2 pt 1 1996 175
248. D.Y. Graham K.S. Hepps F.C. Ramirez G.M. Lew Z.A. Saeed Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease Scand J Gastroenterol 28 1993 939-942
249. J. Labenz G. Borsch Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse Digestion 55 1994 19-23
250. T. Rokkas A. Karameris A. Mavrogeorgis E. Rallis N. Giannikos Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease Gastrointest Endosc 41 1995 1-4
251. D. Jaspersen T. Koerner W. Schorr M. Brennenstuhl C. Raschka C.H. Hammar Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage Gastrointest Endosc 41 1995 5-7
252. T.A. Rockall R.F. Logan H.B. Devlin T.C. Northfield Risk assessment after acute upper gastrointestinal haemorrhage Gut 38 1996 316-321
253. D.M. Jensen Treatment of patients at high risk for recurrent bleeding from a peptic ulcer Ann Intern Med 139 2003 294-295
254. J.A.H. Forrest N.D.C. Finlayson D.J.C. Shearman Endoscopy of upper gastrointestinal bleeding Lancet 2 1974 394-397
255. H.S. Sacks T.C. Chalmers Al Bllum et al. Endoscopic hemostasis: And effective therapy for bleeding peptic ulcers JAMA 264 1990 494
256. S. Naveau C. Perrier B. Mory et al. Endoscopic hemostasis for hemorrhagic gastroduodenal ulcer: Meta-analysis of randomized clinical trials Gastroenterol Clin Biol 15 1991 580-587
257. D.J. Cook G.H. Guyatt B.M. Salena L.A. Laine Endoscopic treatment for acute nonvariceal upper gastrointestinal hemorrhage: A meta-analysis Gastroenterology 102 1992 139-148
258. S. Naveau E. Borotto V. Giraud J.C. Chaput Meta-analysis of endoscopic injection therapy versus thermal methods in peptic ulcer hemorrhage [abstract] Gastroenterology 110 1996 A207
259. J.Y. Lau J.W. Leung Injection therapy for bleeding peptic ulcers Gastrointest Endosc Clin N Am 7 1997 575-591
260. C.P. Choudari C. Rajgopal R.A. Elton K.R. Palmer Failures of endoscopic therapy for bleeding peptic ulcer: An analysis of risk factors Am J Gastroenterol 89 1994 1968-1972
261. J.Y. Lau J.J. Sung Y.H. Lam A.C. Chan E.K. Ng D.W. Lee et al. Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers N Engl J Med 340 1999 751-756
262. R. Marmo G. Rotondano M.A. Bianco R. Piscopo A. Prisco L. Cipolletta Outcome of endoscopic treatment for peptic ulcer bleeding: Is a second look necessary? A meta-analysis Gastrointest Endosc 57 2003 62-67
263. R.C. Wong A. Chak K. Kobayashi G.A. Isenberg G.S. Cooper D.L. Carr-Locke et al. Role of Doppler US in acute peptic ulcer hemorrhage: Can it predict failure of endoscopic therapy? Gastrointest Endosc 52 2000 315-321
264. A.K. Kubba I.C. Choudar C. Rajgopal et al. Reduced low term survival following major peptic ulcer hemorrhage Br J Surg 84 1997 265
265. N. Hudson G. Faulkner S.J. Smith et al. Late mortality in elderly patients surviving peptic ulcer bleeding Gut 37 1995 177
266. M.J. Shapiro The role of the radiologist in the management of gastrointestinal bleeding Gastroenterol Clin North Am 23 1994 123-181
267. D.T. Dempsey D.R. Burke R.S. Reilly et al. Angiography in poor risk patients with massive nonvariceal upper gastrointestinal bleeding Am J Surg 159 1990 282-286
268. R.M. Walsh P. Anain M. Geisinger D. Vogt J. Mayes S. Grundfest-Broniatowski et al. Role of angiography and embolization for massive gastroduodenal hemorrhage [Journal Article] J Gastrointest Surg 3 1999 61-65
269. P.S. Hunt R.L.E. McIntyre Choice of emergency operative procedure for bleeding duodenal ulcer Br J Surg 77 1990 1004-1006
270. J. Hoffmann A. Devantier T. Koelle H.E. Jensen Parietal cell vagotomy as an emergency procedure for bleeding peptic ulcer Ann Surg 206 1987 583-585
271. C.P. Swain D.W. Storey S.G. Bown J. Heath T.N. Mills P.R. Salmon et al. Nature of the bleeding vessel in recurrently bleeding gastric ulcers Gastroenterology 90 1986 595-608
272. P.N. Rogers W.R. Murray R. Shaw S. Brar Surgical management of bleeding gastric ulceration Br J Surg 75 1988 16-17
273. E. Yahchouchy A. Debet A. Fingerhut Crack cocaine-related prepyloric perforation treated laparoscopically Surg Endosc 16 2002 220
274. A.J. Donovan T.V. Berne J.A. Donovan Perforated duodenal ulcer: An alternative therapeutic plan Arch Surg 133 1998 1166-1171
275. T.J. Crofts K.G. Park R.J. Steele S.S. Chung A.K. Li A randomized trial of nonoperative treatment for perforated peptic ulcer N Engl J Med 320 1989 970-973
276. J. Boey J. Wong G.B. Ong A prospective study of operative risk factors in perforated duodenal ulcers Ann Surg 195 1982 265-269
277. C. Tanphiphat T. Tanprayoon A. Na Thalang Surgical treatment of perforated duodenal ulcer: A prospective trial between simple closure and definitive surgery Br J Surg 72 1985 370-372
278. P.H. Jordan Jr J. Thornby Perforated pyloroduodenal ulcers: Long-term results with omental patch closure and parietal cell vagotomy Ann Surg 221 1995 479-488
279. P.H. Jordan Jr C. Morrow Perforated peptic ulcer Surg Clin North Am 68 1988 315-329
280. P.H. Jordan Jr Surgery for peptic ulcer disease Curr Prob Surg 28 1991 265-280
281. S. Sevvel N. Ananthakrishnan V. Kate Role of histamine-2 receptor antagonists after simple closure of perforated duodenal ulcer - a double blind randomised, controlled study Trop Gastroenterol 17 1996 227-229
282. D.H. Reinbach G. Cruickshank K.E. McColl Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection Gut 34 1993 1344-1347
283. N. Katkhouda E. Mavor R.J. Mason et al. Laparoscopic repair of perforated duodenal ulcers Arch Surg 134 1999 845-850
284. W.T. Siu C.H. Chau B.K. Law C.N. Tang P.Y. Ha M.K. Li Routine use of laparoscopic repair for perforated peptic ulcer Br J Surg 91 2004 481-484
285. W.T. Siu H.T. Leong B.K. Law C.H. Chau A.C. Li K.H. Fung et al. Laparoscopic repair for perforated peptic ulcer a randomized controlled trial Ann Surg 235 2002 313-319
286. R.M. Hodnett F. Gonzalez W.C. Lee F.C. Nance R. Deboisblanc The need for definitive therapy in the management of perforated gastric ulcers: review of 202 cases Ann Surg 209 1989 36-39
287. C. Lanng C. Palnaes Hansen A. Christensen C.S. Thagaard M. Lassen A. Klaerke et al. Perforated gastric ulcer Br J Surg 75 1988 758-759
288. P.H. Jordan Jr Type I gastric ulcer treated by parietal cell vagotomy and mucosal ulcerectomy J Am Coll Surg 182 1996 388-393
289. M.P. McDonald T.A. Broughan R.E. Hermann et al. Operations for gastric ulcer: A long-term study Am Surg 62 1996 673-677
290. J.Y.W. Lau S. Chung J.J.Y. Sung et al. Through the scope balloon dilation for pyloric stenosis: Long-term results Gastrointest Endosc 43 1996 98-101
291. J.J. Boylan M.I. Gradzka Long-term results of endoscopic balloon dilation for gastric outlet obstruction Dig Dis Sci 44 1999 1883-1886
292. C.L. Perng H.J. Lin W.C. Lo C.R. Lai W.S. Guo S.D. Lee Characteristics of patients with benign gastric outlet obstruction requiring surgery after endoscopic balloon dilation Am J Gastroenterol 91 1996 987-990
293. J.B. Gibson S.W. Behrman T.C. Fabian L.G. Britt Gastric outlet obstruction resulting from peptic ulcer disease requiring surgical intervention is infrequently associated with helicobacter pylori infection J Am Coll Surg 191 2000 32-37
294. J.J. Gleysteen E.A. Droege Expedient surgical treatment of chronic ulcer stenosis J Clin Gastroenterol 10 1988 619-622
295. D.R. Fischer M.S. Nussbaum T.A. Pritts et al. Use of omeprazole in the management of giant duodenal ulcer results of a prospective study Surgery 126 1999 643-649
296. G.S. Raju K.D. Bardhan C. Royston J. Beresford Giant gastric ulcer: Its natural history and outcome in the H2RA era Am J Gastroenterol 94 1999 3478-3486
297. T.P. Barragry J.W. Blatchford 3rd M.O. Allen Giant gastric ulcers: A review of 49 cases Ann Surg 203 1986 255-259
298. D.M. Simeone A. Hassan J.M. Scheiman Giant peptic ulcer: A surgical or medical disease? Surgery 126 1999 474-478
299. B.D. Schirmer W.C. Meyers J.B. Hanks W.J. Kortz R.S. Jones R.W. Postlethwait Marginal ulcer: A difficult surgical problem Ann Surg 195 1982 653-661
300. P.H. Jordan Jr Indications for parietal cell vagotomy without drainage in gastrointestinal surgery Ann Surg 210 1989 29-41
301. B.I. Hirschowitz A. Lanas Intractable upper gastrointestinal ulceration due to aspirin in patients who have undergone surgery for peptic ulcer Gastroenterology 114 1998 883-892